4.6 Article

A Retrospective Naturalistic Study Comparing the Efficacy of Ketamine and Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression

Related references

Note: Only part of the references are listed.
Review Clinical Neurology

Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis

Anees Bahji et al.

Summary: The study showed that intravenous racemic ketamine was more effective and better tolerated than intranasal esketamine for the treatment of unipolar and bipolar major depression.

JOURNAL OF AFFECTIVE DISORDERS (2021)

Review Clinical Neurology

Efficacy and tolerability of theta-burst stimulation for major depression: A systematic review and meta-analysis

Hsuan-Te Chu et al.

Summary: TBS is a more efficient treatment option for MD with favorable efficacy and tolerability. Research indicates that the TBS group had higher overall effect sizes, leading to improved depression response and remission rates.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2021)

Review Neurosciences

Personalization of Repetitive Transcranial Magnetic Stimulation for the Treatment of Major Depressive Disorder According to the Existing Psychiatric Comorbidity

Po-Han Chou et al.

Summary: Individualized treatment approaches are crucial for increasing treatment response in MDD patients with psychiatric comorbidities. Choosing the most optimal TMS protocol based on the individual profile is essential to improve outcomes. Validation of neuroimaging and electrophysiological biomarkers can help predict rTMS treatment responses.

CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE (2021)

Article Neurosciences

Sustained effects of rapidly acting antidepressants require BDNF-dependent MeCP2 phosphorylation

Ji-Woon Kim et al.

Summary: This study shows that MeCP2 phosphorylation at a specific site downstream of BDNF is essential for the sustained antidepressant effects of ketamine and scopolamine, and plays a critical role in long-term regulation of synaptic strength. These findings highlight the importance of MeCP2 and associated synaptic plasticity in mediating sustained antidepressant effects of ketamine and scopolamine.

NATURE NEUROSCIENCE (2021)

Editorial Material Psychiatry

Esketamine/ketamine for treatment-resistant depression

Acioly L. T. Lacerda

BRAZILIAN JOURNAL OF PSYCHIATRY (2020)

Review Chemistry, Medicinal

Ketamine and depression: a narrative review

Alexandrine Corriger et al.

DRUG DESIGN DEVELOPMENT AND THERAPY (2019)

Letter Clinical Neurology

Intermittent theta burst stimulation for major depression during pregnancy

Alisson P. Trevizol et al.

BRAIN STIMULATION (2019)

Article Clinical Neurology

High-frequency repetitive TMS for suicidal ideation in adolescents with depression

Paul E. Croarkin et al.

JOURNAL OF AFFECTIVE DISORDERS (2018)

Article Social Sciences, Interdisciplinary

Implications of Small Samples for Generalization: Adjustments and Rules of Thumb

Elizabeth Tipton et al.

EVALUATION REVIEW (2017)

Article Neurosciences

Ketamine: 50 Years of Modulating the Mind

Linda Li et al.

FRONTIERS IN HUMAN NEUROSCIENCE (2016)

Review Psychology, Clinical

THETA-BURST STIMULATION: A NEW FORM OF TMS TREATMENT FOR DEPRESSION?

Sung Wook Chung et al.

DEPRESSION AND ANXIETY (2015)

Article Neurosciences

Combination therapy utilizing ketamine and transcranial magnetic stimulation for treatment-resistant depression: a case report

Steven Richard Devore Best et al.

INTERNATIONAL JOURNAL OF NEUROSCIENCE (2015)

Review Clinical Neurology

Transcranial magnetic stimulation for the treatment of major depression

Philip G. Janicak et al.

NEUROPSYCHIATRIC DISEASE AND TREATMENT (2015)

Review Neurosciences

Ketamine administration in depressive disorders: a systematic review and meta-analysis

Guillaume Fond et al.

PSYCHOPHARMACOLOGY (2014)

Review Psychiatry

The expanding evidence base for rTMS treatment of depression

Mark S. George et al.

CURRENT OPINION IN PSYCHIATRY (2013)

Article Psychiatry

Intramuscular ketamine in acute depression: A report on two cases

Chilukuri Harihar et al.

INDIAN JOURNAL OF PSYCHIATRY (2013)

Letter Psychiatry

Long-Term Maintenance With Intramuscular Ketamine for Treatment-Resistant Bipolar II Depression

Cristina Cusin et al.

AMERICAN JOURNAL OF PSYCHIATRY (2012)

Article Health Care Sciences & Services

Mood and Pain Responses to Repeat Dose Intramuscular Ketamine in a Depressed Patient with Advanced Cancer

Claudia Grott Zanicotti et al.

JOURNAL OF PALLIATIVE MEDICINE (2012)

Review Medicine, General & Internal

Treatment-resistant depression: therapeutic trends, challenges, and future directions

Khalid Saad Al-Harbi

PATIENT PREFERENCE AND ADHERENCE (2012)

Article Psychiatry

Identifying HAM-A cutoffs for mild, moderate, and severe generalized anxiety disorder

Louis S. Matza et al.

INTERNATIONAL JOURNAL OF METHODS IN PSYCHIATRIC RESEARCH (2010)

Review Psychiatry

Repetitive transcranial magnetic stimulation for major depressive disorder: A review

Z. Jeff Daskalakis et al.

CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2008)

Article Neurosciences

Antidepressant effects of ketamine in depressed patients

RM Berman et al.

BIOLOGICAL PSYCHIATRY (2000)